Marinomed share wins: Marinomed Biotech announces distribution agreement
Marinomed Biotech has a piece of news on Wednesday to create a good mood among investors.
The biotech company announced that it has entered into an agreement with Perrigo Company to distribute the Marinomed virus blocker “Carragelose” in Finland, Norway, Sweden and France.
On the stock exchange, Marinomed shares rose at times by 0.95 percent to 106.00 euros. Erste Group analysts expect the deal to expand the sales regions for Marinomed’s Carragelose products.
Finanzen.at / APA editors